Omnicell Inc (OMCL) surpasses revenue expectations with robust demand for connected devices, despite facing profitability impacts from tariffs and retail pharmacy headwinds.

Q3 2025 Management View Randall Lipps, Founder, Executive Chairman, President & CEO, announced "another strong quarter" for Omnicell, highlighting that "total revenues, non-GAAP EBITDA and non-GAAP ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced OmniSphere, a ...

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the second quarter 2025, before market open on Thursday, ...

Ratings for Omnicell (NASDAQ:OMCL) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their ...

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the third quarter 2025, before market open on Thursday, ...

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results , with sales up 18.6% year on year to $306.9 million. On the other hand, next quarter’s revenue guidance of $260 million was ...

FORT WORTH, Texas (AP) — FORT WORTH, Texas (AP) — Omnicell Inc. (OMCL) on Thursday reported profit of $5.6 million in its second quarter. On a per-share basis, the Fort Worth, Texas-based company said ...